Timothée Olivier, MD· @Timothee_MD · X·· 1 天前评分70
正文 · 原文
Nice to see the MASTERPLAN study presented #ESMO26 and published in @TheLancetOncol !
Congrats to the authors!
Our new paper :
"A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials"
with @free_radical28 is out in EJC, open access :
https://www.sciencedirect.com/science/article/pii/S0959804926015728
Food for thoughts for ongoing and future trials in that space!👇
365 浏览 · 4 赞 · 3 转发 · 0 回复
会议摘要
3136RO按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Randomised phase II study of mFOLFIRINOX ± SBRT in patients with high risk, borderline resectable or locally advanced pancreatic cancer: Results of the AGITG MASTERPLAN trial
https://esmocongress.esmo.org来源：Timothée Olivier, MD · x.com